MAP3K14 and ST Elevation Myocardial Infarction: In consideration of existing guidelines on non-ST elevation myocardial infarction and to represent daily clinical decision-making, we selected patients with markedly elevated levels of cTnI (i.e., 5 times upper limit of normal, ULN) or a 50% change between two measurements of cTnI or when testing hs-TnT a single value above 52 ng/L or a Delta 0/1 h > 5 ng/L for analysis in this high probability group.